Patent · US Active

Compositions and methods of labeling mitochondrial nucleic acids and sequencing and analysis thereof

US12258615B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 23, 2021
Grant dateMar 25, 2025
Priority date
Expiry dateSep 24, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC40B40/08
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Methods of labeling, amplifying, and sequencing mitochondrial DNA are provided. The labeling methods typically include using polymerase-based extension of one or more unique molecular identifier (UMI) primers along a target mitochondrial DNA template, each UMI primer including a universal primer sequence, a unique molecular identifier sequence, and a mitochondrial DNA binding sequence. Amplification of the labeled-target mitochondrial DNA can include, for example, polymerase chain reaction (e.g., high-fidelity long-range). Methods of determining the sequence of labeled-target mitochondrial DNA can include use of a long-read sequencing platform. The methods may further including one or more of grouping sequences having the same UMI into one of more groups, determining the sequence of each labeled-target mitochondrial DNA by determining the consensus sequence of each group, and identifying polymorphisms in one or more of the labeled-target mitochondrial DNA. The methods can be used in, for example, preimplantation genetic testing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.